Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 2 of 14

RECRUITING

Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder

NCT06576726

RECRUITING NA

The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings

NCT06546696

RECRUITING Phase 1

Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

NCT05856994

RECRUITING NA

Sleep Coach for Adolescents With Type 1 Diabetes

NCT06516614

RECRUITING NA

Neurophysiology of Reward Signaling in Parkinson's Disease

NCT07409207

RECRUITING NA

Home-Based Cardiac Rehabilitation for Patients With Heart Failure

NCT06479876

RECRUITING NA

Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency

NCT06456762

RECRUITING

The APS Phenotyping Study

NCT06521502

RECRUITING

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim

NCT06093100

RECRUITING NA

Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas

NCT06427538

RECRUITING Early Phase 1

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

NCT06338553

RECRUITING NA

Respiratory Strength Training in Heart Transplant Recipients

NCT06190171

RECRUITING NA

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

NCT06299683

RECRUITING NA

Long COVID Immune Profiling

NCT06027255

RECRUITING Early Phase 1

The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease

NCT06113003

RECRUITING

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

NCT06124196

RECRUITING Phase 2

Tranexamic Acid in Nasal Mohs Reconstruction

NCT06057675

RECRUITING Phase 2

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

NCT04941599

RECRUITING

Retinal Vascular Changes During Pregnancy

NCT06311617

RECRUITING NA

Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy

NCT06202443

RECRUITING NA

Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions

NCT06077201

RECRUITING

Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation

NCT06647459

RECRUITING

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

NCT06575881

RECRUITING Phase 3

Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor

NCT05834777

RECRUITING Early Phase 1

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

NCT04469842

RECRUITING Phase 2

Treating Exacerbations of Asthma With Oral Montelukast in Children

NCT05819541

RECRUITING Phase 4

Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia

NCT05988710

RECRUITING Phase 2

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

NCT05288790

RECRUITING

Assessment of the Ocular Microbiome in Health and Disease

NCT05414994

RECRUITING Phase 1

The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function

NCT05972564

RECRUITING Phase 3

Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer

NCT05999630

RECRUITING NA

Reciprocal Imitation Training and Musical Rhythm Sensitivity in Autistic Toddlers

NCT05880225

RECRUITING Phase 3

CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

NCT05422534

RECRUITING Phase 4

SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery

NCT05812755

RECRUITING Phase 2

Depressed Mood Improvement Through Nicotine Dosing 3

NCT05746273

RECRUITING Phase 1

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

NCT05774717

RECRUITING Phase 4

VZV in the Enteric Nervous System: Pathogenesis and Consequences

NCT05550194

RECRUITING NA

Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation

NCT05650710

RECRUITING Phase 2

Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

NCT05375968

RECRUITING

3D Specimen Maps for RT Planning

NCT05743569

RECRUITING Phase 4

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

NCT05357612

RECRUITING

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

NCT05462574

RECRUITING NA

The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

NCT05464095

RECRUITING Early Phase 1

MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing

NCT05505110

RECRUITING Phase 2

High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

NCT05215327

RECRUITING NA

Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA

NCT05501236

RECRUITING

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

NCT05584722

RECRUITING Phase 2

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

NCT05254314

RECRUITING

Cooperative Assessment of Late Effects for SCD Curative Therapies

NCT05153967

RECRUITING NA

CPAP for the Treatment of Supine Hypertension

NCT05489575

← Previous Page 2 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets.Report a data error.